FundedIQ
Community and Lifestyle

Butterfly Medical

Butterfly Medical is a medical-device start-up that aims to improve the standard of care for men suffering from Benign Prostate Hyperplasia (BPH) or enlarged prostate. The company has developed a fast, simple and minimally invasive alternative treatment to first-line BPH medication and surgery. Butterfly Medical’s patented device can be placed in under 10 minutes, in-office, under local anesthesia, without surgical incision, heating or prostate tissue removal. The device aims to be the only in-office BPH treatment that delivers a long-term, effective solution with minimal side effects, requiring no hospitalization or general anesthesia. Early results from clinical trials are very promising with blocked urethras successfully opened and patients suffering no side effects. Further clinical studies are starting in leading medical centers in Europe. Visit www.butterfly-medical.com for more information.

www.butterfly-medical.com Yoqne`am `illit, Israel 1-10 employees
Total raised
$21.0M
Rounds
1
Latest
Series C
May 2026

Butterfly Medical is a medical-device start-up that aims to improve the standard of care for men suffering from Benign Prostate Hyperplasia (BPH) or enlarged prostate. The company has developed a fast, simple and minimally invasive alternative treatment to first-line BPH medication and surgery. Butterfly Medical’s patented device can be placed in under 10 minutes, in-office, under local anesthesia, without surgical incision, heating or prostate tissue removal. The device aims to be the only in-office BPH treatment that delivers a long-term, effective solution with minimal side effects, requiring no hospitalization or general anesthesia. Early results from clinical trials are very promising with blocked urethras successfully opened and patients suffering no side effects. Further clinical studies are starting in leading medical centers in Europe. Visit www.butterfly-medical.com for more information.

Butterfly Medical has raised $21.0M across 1 round. Its most recent round was a Series C of $21.0M in May 2026. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
May 14, 2026
Series C
$21.0M

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Butterfly Medical is featured in

Similar companies

InterCure

InterCure is a manufacturer and distributor of pharmaceutical medical cannabis products.

Series Unknown $7.4M
IM Cannabis

IM Cannabis is a company that manufactures and disseminates medical marijuana. They provide various products for patients and conduct research to develop innovative genetic strains. IM Cannabis was established by Oren Shuster and Rafael Gabay in Glil Yam, Tel Aviv, in 2010.

Series Unknown $550k
ELSE Nutrition

Else Nutrition offers plant-based nutrition products for the infant, toddler, children, and adult markets. It develops a plant-based non-soy alternative to dairy-based baby formula.

Series Unknown $1.3M
Jotit

Jotit is an innovative educational technology company that utilizes handwriting tools to assist children, teachers, and parents in remaining organized.

Series Unknown
FEMSelect

FEMSelect is revolutionizing women's health with their cutting-edge technology platform. They have developed EnPlace, a mesh-free system for pelvic floor ligament fixation that can be inserted in about 30 minutes. Their patented delivery system ensures accurate guidance, insertion, and deployment of the anchor unit, which is designed to stabilize the pelvic floor ligament after being secured through the vaginal wall. Founded in 2012, FEMSelect is based in Modi'in, Israel.

Series B
ConTIPI Medical

ConTIPI Medical offers vaginal solutions that are disposable and non-surgical for women with various Pelvic Floor Disorders (PFD's). These solutions allow women to directly manage their condition and have already been successfully developed and brought to market. The Impressa Device, marketed by Kimberly Clark Inc. under the Poise® brand, is an example of this concept and is used for Stress Urinary Incontinence. ConTIPI Medical's second product, the ProVate Device, is intended for non-surgical management of Pelvic Organ Prolapse (POP) and has received a CE Mark for marketing in the EU. It is currently undergoing final clinical studies in the USA. Both devices are delivered in a wrapper and can be easily used at home. They are inserted vaginally using an applicator, which compresses them to a small size. Once inserted, the applicator deploys the device, providing support to specific areas along the vaginal walls. At the end of use, the device is removed with a pull of a string, reducing its size and then disposed of. These devices empower women to take control of their medical issues and use them in privacy and convenience. The ProVate device was specifically designed for women with Pelvic Organ Prolapse who prefer non-invasive management. Traditional pessaries have high discontinuation rates and many users are reluctant to use reusable devices that are difficult to insert and remove. The ProVate disposable device solves these issues by providing vaginal support that can be inserted and removed by the user at home.

Series Unknown $40.0M
daily.dev

The Daily Dev platform provides a community of developers with opportunities to expand their knowledge, work together, and advance in their careers.

Seed $11.0M
Crowdvocate

Crowdvocate helps B2B organizations draw in their clients consequently (trigger-based) all through their life-cycle, and enact them for different exercises like support, criticism, references, upsell, social enhancement, and that's just the beginning. Our omnichannel and in-application modules empower frictionless client cooperations at scale, and our use systems permit utilizing the voice of the clients (VOC) for business development. We give a self-serve device to B2B organizations to use their groups = their Customers, Partners, Eco-framework, and Employees, and prepare them to become brand advocates. Our vision is to empower organizations to encounter the best development strategy, at incredible ROI, through arranged and robotized informal. Crowdvocate increments references, references, item audits, positioning, reliability, client based lead age, swarm based content creation, ideation and considerably more.

Venture - Series Unknown $15.0M
Mindspace

Mindspace is a boutique flex space provider, presenting a global mindset with a local flavor. We redefine the workplace experience for companies of all sizes. Our beautifully designed spaces, personalized level of service and carefully curated events foster enhanced employee engagement and a strong sense of community, accommodating the way people work, innovate and grow. Our customer base includes blue-chip companies, enterprises and SMBs, in 31 locations, 16 cities and 7 countries across Europe and the US.

Venture - Series Unknown $72.0M
Noveto Systems

Noveto Systems produces focussed audio solutions, creating Virtual Headphones - Headphones without Headphones

$10.0M
HelloVote

HelloVote is a developer of voter engagement platform simplifying registration, election information, and civic participation.

Seed $20k
Los Sundays Tequila

Los Sundays is a lifestyle brand disrupting a product-focused category. Strategically built to engage organically with consumers through today's most influential channels – social media, fashion, and immersive events. Los Sundays combines original and relatable content with award-winning tequila to captivate and inspire the new generation of tequila consumers.

Series Unknown
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.